Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Keaton S. Smetana, Rachel Ziemba, Casey C. May, Michael J. Erdman, Edward T. Van Matre, G. Morgan Jones

ABSTRACT

The package insert of 4-factor prothrombin complex concentrate (4F-PCC) contains specific dosing recommendations stating to determine the patients dose based on their INR and weight, capping the weight at 100 kg. However, the mean body mass index (BMI) in the 4F-PCC U.S. approval study was 27 kg/m2, and there is a lack of literature identifying the ideal dosing strategy in obesity. We conducted a retrospective analysis of obese patients (BMI ≥ 30 kg/m2) who received 4F-PCC for warfarin associated emergent bleeding reversal. Treatment groups were those that received 4F-PCC on adjusted body weight (AdjBW) and those on actual body weight (ActBW). The primary outcome was the percent of patients achieving coagulopathy reversal, defined as a post-treatment INR < 1.4 for neurologic indications and < 1.5 for all others. A total of 78 obese patients were included (28 AdjBW and 50 ActBW). Baseline INR (3.1 vs. 2.8; p = 0.052) and BMI (33.6 vs. 33.6 kg/m2) were similar between groups. Achievement of goal INR was significantly lower in the AdjBW group (36% vs. 68%; p = 0.006). A majority of patients had intracranial hemorrhage (32% vs. 54%; p = 0.06), and the median dose of 4F-PCC was lower in the AdjBW group (2120 vs. 2500 units; p = 0.02). Dosing 4F-PCC using adjusted body weight in obese patients resulted in a significantly lower rate of coagulopathy reversal. ActBW should be used to dose 4F-PCC in obese patients when the 100 kg dose cap is utilized per the package insert recommendations. More... »

PAGES

369-374

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-018-1771-6

DOI

http://dx.doi.org/10.1007/s11239-018-1771-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110063060

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30460443


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Doan Hall Room 368, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smetana", 
        "givenName": "Keaton S.", 
        "id": "sg:person.016635170627.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016635170627.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University", 
          "id": "https://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "The Ohio State University College of Pharmacy, 500 W 12th Ave, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ziemba", 
        "givenName": "Rachel", 
        "id": "sg:person.07644335733.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07644335733.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Doan Hall Room 368, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "May", 
        "givenName": "Casey C.", 
        "id": "sg:person.01315104055.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315104055.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Florida Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.413116.0", 
          "name": [
            "Department of Pharmacy, University of Florida Health, 655 West 8th Street, 32209, Jacksonville, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Erdman", 
        "givenName": "Michael J.", 
        "id": "sg:person.0735310360.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735310360.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tennessee Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.267301.1", 
          "name": [
            "Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Sciences Center, 881 Madison Avenue, 38163, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Van Matre", 
        "givenName": "Edward T.", 
        "id": "sg:person.01356346035.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356346035.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tennessee Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.267301.1", 
          "name": [
            "Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Sciences Center, 881 Madison Avenue, 38163, Memphis, TN, USA", 
            "Department of Pharmacy, Methodist University Hospital, 1265 Union Avenue, 38104, Memphis, TN, USA", 
            "Departments of Neurology and Neurosurgery, UTHSC, 920 Court Ave, 38163, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jones", 
        "givenName": "G. Morgan", 
        "id": "sg:person.01042563235.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042563235.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.dld.2015.03.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001436603"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2036.2011.04618.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011578959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12028-015-0222-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012962547", 
          "https://doi.org/10.1007/s12028-015-0222-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-199325020-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021673614", 
          "https://doi.org/10.2165/00003088-199325020-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-199325020-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021673614", 
          "https://doi.org/10.2165/00003088-199325020-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1537-2995.2012.03849.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027177395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/hae.12300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027302797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2016.155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032557062", 
          "https://doi.org/10.1038/ajg.2016.155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2016.155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032557062", 
          "https://doi.org/10.1038/ajg.2016.155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.113.002283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039649864"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.113.002283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039649864"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1381/096089206777346673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047809603", 
          "https://doi.org/10.1381/096089206777346673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-015-1330-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048929484", 
          "https://doi.org/10.1007/s11239-015-1330-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.14740/jh256w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067358425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5694/mja13.10685", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073073523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5694/mja13.10685", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073073523"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "The package insert of 4-factor prothrombin complex concentrate (4F-PCC) contains specific dosing recommendations stating to determine the patients dose based on their INR and weight, capping the weight at 100\u00a0kg. However, the mean body mass index (BMI) in the 4F-PCC U.S. approval study was 27\u00a0kg/m2, and there is a lack of literature identifying the ideal dosing strategy in obesity. We conducted a retrospective analysis of obese patients (BMI\u2009\u2265\u200930\u00a0kg/m2) who received 4F-PCC for warfarin associated emergent bleeding reversal. Treatment groups were those that received 4F-PCC on adjusted body weight (AdjBW) and those on actual body weight (ActBW). The primary outcome was the percent of patients achieving coagulopathy reversal, defined as a post-treatment INR\u2009<\u20091.4 for neurologic indications and <\u20091.5 for all others. A total of 78 obese patients were included (28 AdjBW and 50 ActBW). Baseline INR (3.1 vs. 2.8; p\u2009=\u20090.052) and BMI (33.6 vs. 33.6\u00a0kg/m2) were similar between groups. Achievement of goal INR was significantly lower in the AdjBW group (36% vs. 68%; p\u2009=\u20090.006). A majority of patients had intracranial hemorrhage (32% vs. 54%; p\u2009=\u20090.06), and the median dose of 4F-PCC was lower in the AdjBW group (2120 vs. 2500 units; p\u2009=\u20090.02). Dosing 4F-PCC using adjusted body weight in obese patients resulted in a significantly lower rate of coagulopathy reversal. ActBW should be used to dose 4F-PCC in obese patients when the 100\u00a0kg dose cap is utilized per the package insert recommendations.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-018-1771-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "name": "Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding", 
    "pagination": "369-374", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8330f50cd483a366faa2ae3d1693fd17e209e95a3ad84b5bf79c7860ed5cc1ae"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30460443"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-018-1771-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110063060"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-018-1771-6", 
      "https://app.dimensions.ai/details/publication/pub.1110063060"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000370_0000000370/records_46760_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11239-018-1771-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-018-1771-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-018-1771-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-018-1771-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-018-1771-6'


 

This table displays all metadata directly associated to this object as RDF triples.

156 TRIPLES      21 PREDICATES      41 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-018-1771-6 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N075660ab3a6847739676551d9b1ad7ff
4 schema:citation sg:pub.10.1007/s11239-015-1330-3
5 sg:pub.10.1007/s12028-015-0222-x
6 sg:pub.10.1038/ajg.2016.155
7 sg:pub.10.1381/096089206777346673
8 sg:pub.10.2165/00003088-199325020-00003
9 https://doi.org/10.1016/j.dld.2015.03.029
10 https://doi.org/10.1111/hae.12300
11 https://doi.org/10.1111/j.1365-2036.2011.04618.x
12 https://doi.org/10.1111/j.1537-2995.2012.03849.x
13 https://doi.org/10.1161/circulationaha.113.002283
14 https://doi.org/10.14740/jh256w
15 https://doi.org/10.5694/mja13.10685
16 schema:datePublished 2019-04
17 schema:datePublishedReg 2019-04-01
18 schema:description The package insert of 4-factor prothrombin complex concentrate (4F-PCC) contains specific dosing recommendations stating to determine the patients dose based on their INR and weight, capping the weight at 100 kg. However, the mean body mass index (BMI) in the 4F-PCC U.S. approval study was 27 kg/m<sup>2</sup>, and there is a lack of literature identifying the ideal dosing strategy in obesity. We conducted a retrospective analysis of obese patients (BMI ≥ 30 kg/m<sup>2</sup>) who received 4F-PCC for warfarin associated emergent bleeding reversal. Treatment groups were those that received 4F-PCC on adjusted body weight (AdjBW) and those on actual body weight (ActBW). The primary outcome was the percent of patients achieving coagulopathy reversal, defined as a post-treatment INR &lt; 1.4 for neurologic indications and &lt; 1.5 for all others. A total of 78 obese patients were included (28 AdjBW and 50 ActBW). Baseline INR (3.1 vs. 2.8; p = 0.052) and BMI (33.6 vs. 33.6 kg/m<sup>2</sup>) were similar between groups. Achievement of goal INR was significantly lower in the AdjBW group (36% vs. 68%; p = 0.006). A majority of patients had intracranial hemorrhage (32% vs. 54%; p = 0.06), and the median dose of 4F-PCC was lower in the AdjBW group (2120 vs. 2500 units; p = 0.02). Dosing 4F-PCC using adjusted body weight in obese patients resulted in a significantly lower rate of coagulopathy reversal. ActBW should be used to dose 4F-PCC in obese patients when the 100 kg dose cap is utilized per the package insert recommendations.
19 schema:genre research_article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N57189c5b65134008afb132d454b79cc9
23 Ne2d797a7f72f4aa3a9697a907540d19e
24 sg:journal.1113719
25 schema:name Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding
26 schema:pagination 369-374
27 schema:productId N020fd4ed8b98449cbf10e74f483bf6dd
28 N40deb55aa14741a99a4bc0f51faaec90
29 N5fbc8cce634f49eba60f6f07b295d29a
30 N791197bad1d949e79ea492c7802accd6
31 N8610e8cdfefb4ed6ac4923f1cba171d6
32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110063060
33 https://doi.org/10.1007/s11239-018-1771-6
34 schema:sdDatePublished 2019-04-11T13:32
35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
36 schema:sdPublisher N00c243cd6f4942cb99db528b7edf6f56
37 schema:url https://link.springer.com/10.1007%2Fs11239-018-1771-6
38 sgo:license sg:explorer/license/
39 sgo:sdDataset articles
40 rdf:type schema:ScholarlyArticle
41 N00c243cd6f4942cb99db528b7edf6f56 schema:name Springer Nature - SN SciGraph project
42 rdf:type schema:Organization
43 N020fd4ed8b98449cbf10e74f483bf6dd schema:name dimensions_id
44 schema:value pub.1110063060
45 rdf:type schema:PropertyValue
46 N02f8a032151743dc950568f2a3c93b71 rdf:first sg:person.01315104055.39
47 rdf:rest N1ebf5b02513b4dfa91e8f7015f57999a
48 N075660ab3a6847739676551d9b1ad7ff rdf:first sg:person.016635170627.93
49 rdf:rest N6bf0ae5766ae46c68123b63d9ecba15c
50 N0a0d882f04fe4b36bf685d87d6d1d763 rdf:first sg:person.01356346035.99
51 rdf:rest Ncfb76e773df0482e911d274112f25496
52 N1ebf5b02513b4dfa91e8f7015f57999a rdf:first sg:person.0735310360.13
53 rdf:rest N0a0d882f04fe4b36bf685d87d6d1d763
54 N40deb55aa14741a99a4bc0f51faaec90 schema:name readcube_id
55 schema:value 8330f50cd483a366faa2ae3d1693fd17e209e95a3ad84b5bf79c7860ed5cc1ae
56 rdf:type schema:PropertyValue
57 N57189c5b65134008afb132d454b79cc9 schema:volumeNumber 47
58 rdf:type schema:PublicationVolume
59 N5fbc8cce634f49eba60f6f07b295d29a schema:name doi
60 schema:value 10.1007/s11239-018-1771-6
61 rdf:type schema:PropertyValue
62 N6bf0ae5766ae46c68123b63d9ecba15c rdf:first sg:person.07644335733.93
63 rdf:rest N02f8a032151743dc950568f2a3c93b71
64 N791197bad1d949e79ea492c7802accd6 schema:name nlm_unique_id
65 schema:value 9502018
66 rdf:type schema:PropertyValue
67 N8610e8cdfefb4ed6ac4923f1cba171d6 schema:name pubmed_id
68 schema:value 30460443
69 rdf:type schema:PropertyValue
70 Ncfb76e773df0482e911d274112f25496 rdf:first sg:person.01042563235.91
71 rdf:rest rdf:nil
72 Ne2d797a7f72f4aa3a9697a907540d19e schema:issueNumber 3
73 rdf:type schema:PublicationIssue
74 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
75 schema:name Medical and Health Sciences
76 rdf:type schema:DefinedTerm
77 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
78 schema:name Clinical Sciences
79 rdf:type schema:DefinedTerm
80 sg:journal.1113719 schema:issn 0929-5305
81 1573-742X
82 schema:name Journal of Thrombosis and Thrombolysis
83 rdf:type schema:Periodical
84 sg:person.01042563235.91 schema:affiliation https://www.grid.ac/institutes/grid.267301.1
85 schema:familyName Jones
86 schema:givenName G. Morgan
87 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042563235.91
88 rdf:type schema:Person
89 sg:person.01315104055.39 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
90 schema:familyName May
91 schema:givenName Casey C.
92 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315104055.39
93 rdf:type schema:Person
94 sg:person.01356346035.99 schema:affiliation https://www.grid.ac/institutes/grid.267301.1
95 schema:familyName Van Matre
96 schema:givenName Edward T.
97 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356346035.99
98 rdf:type schema:Person
99 sg:person.016635170627.93 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
100 schema:familyName Smetana
101 schema:givenName Keaton S.
102 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016635170627.93
103 rdf:type schema:Person
104 sg:person.0735310360.13 schema:affiliation https://www.grid.ac/institutes/grid.413116.0
105 schema:familyName Erdman
106 schema:givenName Michael J.
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735310360.13
108 rdf:type schema:Person
109 sg:person.07644335733.93 schema:affiliation https://www.grid.ac/institutes/grid.261331.4
110 schema:familyName Ziemba
111 schema:givenName Rachel
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07644335733.93
113 rdf:type schema:Person
114 sg:pub.10.1007/s11239-015-1330-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048929484
115 https://doi.org/10.1007/s11239-015-1330-3
116 rdf:type schema:CreativeWork
117 sg:pub.10.1007/s12028-015-0222-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012962547
118 https://doi.org/10.1007/s12028-015-0222-x
119 rdf:type schema:CreativeWork
120 sg:pub.10.1038/ajg.2016.155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032557062
121 https://doi.org/10.1038/ajg.2016.155
122 rdf:type schema:CreativeWork
123 sg:pub.10.1381/096089206777346673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047809603
124 https://doi.org/10.1381/096089206777346673
125 rdf:type schema:CreativeWork
126 sg:pub.10.2165/00003088-199325020-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021673614
127 https://doi.org/10.2165/00003088-199325020-00003
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/j.dld.2015.03.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001436603
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1111/hae.12300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027302797
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1111/j.1365-2036.2011.04618.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011578959
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1111/j.1537-2995.2012.03849.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027177395
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1161/circulationaha.113.002283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039649864
138 rdf:type schema:CreativeWork
139 https://doi.org/10.14740/jh256w schema:sameAs https://app.dimensions.ai/details/publication/pub.1067358425
140 rdf:type schema:CreativeWork
141 https://doi.org/10.5694/mja13.10685 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073073523
142 rdf:type schema:CreativeWork
143 https://www.grid.ac/institutes/grid.261331.4 schema:alternateName The Ohio State University
144 schema:name The Ohio State University College of Pharmacy, 500 W 12th Ave, 43210, Columbus, OH, USA
145 rdf:type schema:Organization
146 https://www.grid.ac/institutes/grid.267301.1 schema:alternateName University of Tennessee Health Science Center
147 schema:name Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Sciences Center, 881 Madison Avenue, 38163, Memphis, TN, USA
148 Department of Pharmacy, Methodist University Hospital, 1265 Union Avenue, 38104, Memphis, TN, USA
149 Departments of Neurology and Neurosurgery, UTHSC, 920 Court Ave, 38163, Memphis, TN, USA
150 rdf:type schema:Organization
151 https://www.grid.ac/institutes/grid.412332.5 schema:alternateName The Ohio State University Wexner Medical Center
152 schema:name Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Doan Hall Room 368, 43210, Columbus, OH, USA
153 rdf:type schema:Organization
154 https://www.grid.ac/institutes/grid.413116.0 schema:alternateName University of Florida Health Science Center
155 schema:name Department of Pharmacy, University of Florida Health, 655 West 8th Street, 32209, Jacksonville, FL, USA
156 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...